A proposal to promote the development and use of substitutes for endangered animal and plant ingredients in traditional Chinese medicine (TCM) was submitted at China’s annual plenary sessions of the National People's Congress this month
Today, we’re sharing a flashback to a film we made in 2015 to accompany a major Wildlife team investigation and report into Laos’ notorious Sin City
EIA sent teams of campaigners from our UK and US offices to the 77th meeting of the Standing Committee (SC77) of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES)
EIA will be actively engaging at SC77 on a suite of issues important to the protection of elephants, rhinos, tigers, pangolins, vaquita and rosewood, as well as compliance and enforcement of CITES more broadly. Read on for a summary of EIA’s priorities at SC77 and check out our detailed SC77 Briefing with full comments and recommendations.
Illegal wildlife trade is happening on a large scale to supply the parts and products of protected species such as leopards, pangolins, rhinos and tigers to serve as ingredients in some traditional Chinese medicines – and some big international household names are invested
A new EIA UK investigation has found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 traditional Chinese medicine (TCM) products